National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review

Anesthesia and Analgesia

Volumn 124, Issue 1, 2017, Pages 216-232

  Shaylor, Ruth ^a   Weiniger, Carolyn F ^a   Austin, Naola ^b   Tzabazis, Alexander ^b   Shander, Aryeh ^c,d   Goodnough, Lawrence T ^b   Butwick, Alexander J ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; TRANEXAMIC ACID;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CESAREAN SECTION; CRYOPRECIPITATE; HUMAN; HYPOFIBRINOGENEMIA; OBSTETRICS; PARTIAL THROMBOPLASTIN TIME; PATIENT BLOOD MANAGEMENT; PLACENTA ACCRETA; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; VAGINAL DELIVERY; ADVERSE EFFECTS; BLOOD; CLINICAL PRACTICE; CONSENSUS; FEMALE; MEDICAL SOCIETY; POSTPARTUM HEMORRHAGE; PREGNANCY; PROTOCOL COMPLIANCE; RISK FACTOR; STANDARDS; TREATMENT OUTCOME;

BLOOD TRANSFUSION; CONSENSUS; FEMALE; GUIDELINE ADHERENCE; HUMANS; OBSTETRICS; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PREGNANCY; RISK FACTORS; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 84983268215     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001473     Document Type: Article

References (104)

1. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009;9:55.
2. Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol. 2012;120:1029-1036.
3. Institute of Medicine Committee. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press; 1990.
4. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527-530.
5. Jackson R, Feder G. Guidelines for clinical guidelines. BMJ. 1998;317:427-428.
6. Schmidt C. Conflicting clinical guidelines. J Natl Cancer Inst. 2013;105:2-3.
7. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.
8. Royal College of Obstetricians and Gynaecologists. Prevention and Management of Postpartum Haemorrhage (Green-top Guideline 52). London: RCOG; 2009.
9. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of Postpartum Hemorrhage, March 2011. Available at: http://www.ranzcog.edu.au/college-statements-guidelines.html. Accessed April 15, 2016.
10. Dahlke JD, Mendez-Figueroa H, Maggio L, et al. Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines. Am J Obstet Gynecol. 2015;213:76.e1-10.
11. Goodnough LT, Shander A. Patient blood management. Anesthesiology. 2012;116:1367-1376.
12. Holcomb JB, Tilley BC, Baraniuk S, et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313:471-482.
13. Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol. 2015;28:275-284.
14. Gutierrez MC, Goodnough LT, Druzin M, Butwick AJ. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int J Obstet Anesth. 2012;21:230-235.
15. Ducloy-Bouthors AS, Susen S, Wong CA, Butwick A, Vallet B, Lockhart E. Medical advances in the treatment of postpartum hemorrhage. Anesth Analg. 2014;119:1140-1147.
16. Leduc D, Senikas V, Lalonde AB, et al; Clinical Practice Obstetrics Committee; Society of Obstetricians and Gynaecologists of Canada. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2009;31:980-993.
17. Postpartum hemorrhage. ACOG Practice Bulletin No.76. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2006;108:1039-1047.
18. Sentilhes L, Vayssière C, Deneux-Tharaux C, et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016;198:12-21.
19. Schlembach D, Mörtl MG, Girard T, et al. [Management of postpartum hemorrhage (PPH): algorithm of the interdisciplinary D-A-CH consensus group PPH (Germany-Austria-Switzerland)]. Anaesthesist. 2014;63:234-242.
20. Abdul-Kadir R, McLintock C, Ducloy AS, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014;54:1756-1768.
21. Main EK, Goffman D, Scavone BM, et al; National Partnership for Maternal Safety; Council for Patient Safety in Women's Health Care. National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage. Anesth Analg. 2015;121:142-148.
22. Tunçalp O, Souza JP, Gülmezoglu M; World Health Organization. New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynaecol Obstet. 2013;123:254-256.
23. Lalonde A; International Federation of Gynecology and Obstetrics. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117:108-118.
24. Carson JL, Grossman BJ, Kleinman S, et al; Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157:49-58.
25. Kaufman RM, Djulbegovic B, Gernsheimer T, et al; AABB. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162:205-213.
26. Roback JD, Caldwell S, Carson J, et al; American Association for the Study of Liver; American Academy of Pediatrics; United States Army; American Society of Anesthesiology; American Society of Hematology. Evidence-based practice guidelines for plasma transfusion. Transfusion. 2010;50:1227-1239.
27. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015;122:241-275.
28. Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K; British Committee for Standards in Haematology. A practical guideline for the haematological management of major haemorrhage. Br J Haematol. 2015;170:788-803.
29. National Blood Authority (NBA). Patient Blood Management Guidelines: Module 5-Obstetrics and Maternity. Canberra, Australia: NBA; 2015.
30. Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia. 2016;71:829-842.
31. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ. 2003;169:207-208.
32. Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia. 2015;70(suppl 1):78-86, e27-e28.
33. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth. 2012;109:851-863.
34. Montori VM, Brito JP, Murad MH. The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines. JAMA. 2013;310:2503-2504.
35. IOM (Institute of Medicine). Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press; 2011.
36. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318:593-596.
37. Patterson JA, Roberts CL, Isbister JP, et al. What factors contribute to hospital variation in obstetric transfusion rates? Vox Sang. 2015;108:37-45.
38. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG. 2006;113:919-924.
39. Stafford I, Dildy GA, Clark SL, Belfort MA. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol. 2008;199:519.e1-519.e7.
40. Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA. The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg. 2007;105:1736-1740.
41. Lilley G, Burkett-St-Laurent D, Precious E, et al. Measurement of blood loss during postpartum haemorrhage. Int J Obstet Anesth. 2015;24:8-14.
42. Hancock A, Weeks AD, Lavender DT. Is accurate and reliable blood loss estimation the 'crucial step' in early detection of postpartum haemorrhage: an integrative review of the literature. BMC Pregnancy Childbirth. 2015;15:230.
43. Shields LE, Wiesner S, Fulton J, Pelletreau B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. Am J Obstet Gynecol. 2015;212:272-280.
44. Pacagnella RC, Souza JP, Durocher J, et al. A systematic review of the relationship between blood loss and clinical signs. PLoS One. 2013;8:e57594.
45. Parks JK, Elliott AC, Gentilello LM, Shafi S. Systemic hypotension is a late marker of shock after trauma: a validation study of Advanced Trauma Life Support principles in a large national sample. Am J Surg. 2006;192:727-731.
46. Nuttall GA, Stehling LC, Beighley CM, Faust RJ; American Society of Anesthesiologists Committee on Transfusion Medicine. Current transfusion practices of members of the American Society of Anesthesiologists: a survey. Anesthesiology. 2003;99:1433-1443.
47. Armstrong S, Fernando R, Columb M. Minimally-and noninvasive assessment of maternal cardiac output: go with the flow! Int J Obstet Anesth. 2011;20:330-340.
48. Gouveia V, Marcelino P, Reuter DA. The role of transesophageal echocardiography in the intraoperative period. Curr Cardiol Rev. 2011;7:184-196.
49. Rice MJ, Gravenstein N, Morey TE. Noninvasive hemoglobin monitoring: how accurate is enough? Anesth Analg. 2013;117:902-907.
50. Bingham D, Melsop K, Main E. CMQCC Obstetric Hemorrhage Toolkit Hospital Level Implementation Guide. The California Maternal Quality Care Collaborative (CMQCC). Palo Alto, CA: Stanford University; 2010.
51. Wu E, Jolley JA, Hargrove BA, Caughey AB, Chung JH. Implementation of an obstetric hemorrhage risk assessment: validation and evaluation of its impact on pretransfusion testing and hemorrhage outcomes. J Matern Fetal Neonatal Med. 2015;28:71-76.
52. Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk stratification criteria for peripartum hemorrhage. Obstet Gynecol. 2013;122:120-126.
53. Dexter F, Epstein RH. Applying systematic criteria for type and screen based on procedure's probability of erythrocyte transfusion. Anesthesiology. 2014;120:241.
54. Frank SM, Rothschild JA, Masear CG, et al. Optimizing preoperative blood ordering with data acquired from an anesthesia information management system. Anesthesiology. 2013;118:1286-1297.
55. Rinehart JB, Lee TC, Kaneshiro K, Tran MH, Sun C, Kain ZN. Perioperative blood ordering optimization process using information from an anesthesia information management system. Transfusion. 2016;56:938-945.
56. Goodnough LT, Spain DA, Maggio P. Logistics of transfusion support for patients with massive hemorrhage. Curr Opin Anaesthesiol. 2013;26:208-214.
57. Boisen ML, Collins RA, Yazer MH, Waters JH. Pretransfusion testing and transfusion of uncrossmatched erythrocytes. Anesthesiology. 2015;122:191-195.
58. Goodnough LT, Daniels K, Wong AE, Viele M, Fontaine MF, Butwick AJ. How we treat: transfusion medicine support of obstetric services. Transfusion. 2011;51:2540-2548.
59. Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers' lives: reviewing maternal deaths to make motherhood safer-2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH; 2007.
60. Mhyre JM, Shilkrut A, Kuklina EV, et al. Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007. Obstet Gynecol. 2013;122:1288-1294.
61. Clark SL, Hankins GD. Preventing maternal death: 10 clinical diamonds. Obstet Gynecol. 2012;119:360-364.
62. Kacmar RM, Mhyre JM, Scavone BM, Fuller AJ, Toledo P. The use of postpartum hemorrhage protocols in United States academic obstetric anesthesia units. Anesth Analg. 2014;119:906-910.
63. Janelle GM, Shore-Lesserson L, Smith CE, Levy JH, Shander A. What is the PROPPR transfusion strategy in trauma resuscitation? Anesth Analg. 2016;122:1216-1219.
64. van der Bom JG. Rotem in postpartum hemorrhage. Blood. 2014;124:1700-1701.
65. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with metaanalysis and trial sequential analysis. BMJ. 2015;350:h1354.
66. Spahn DR, Spahn GH, Stein P. Evidence base for restrictive transfusion triggers in high-risk patients. Transfus Med Hemother. 2015;42:110-114.
67. Goodnough LT, Maggio P, Hadhazy E, et al. Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion. 2014;54:2753-2759.
68. Oliver JC, Griffin RL, Hannon T, Marques MB. The success of our patient blood management program depended on an institution-wide change in transfusion practices. Transfusion. 2014;54:2617-2624.
69. Roubinian NH, Escobar GJ, Liu V, et al; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III). Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion. 2014;54:2678-2686.
70. Yerrabothala S, Desrosiers KP, Szczepiorkowski ZM, Dunbar NM. Significant reduction in red blood cell transfusions in a general hospital after successful implementation of a restrictive transfusion policy supported by prospective computerized order auditing. Transfusion. 2014;54:2640-2645.
71. Prick BW, Jansen AJ, Steegers EA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG. 2014;121:1005-1014.
72. Gaynes BN, Gavin N, Melzer-Brody S, et al. Perinatal Depression: Prevalence, Screening Accuracy, and Screening Outcomes. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
73. Corwin EJ, Murray-Kolb LE, Beard JL. Low hemoglobin level is a risk factor for postpartum depression. J Nutr. 2003;133:4139-4142.
74. Eckerdal P, Kollia N, Löfblad J, et al. Delineating the association between heavy postpartum haemorrhage and postpartum depression. PLoS One. 2016;11:e0144274.
75. Lee KA, Zaffke ME. Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 1999;28:183-191.
76. Beard JL, Hendricks MK, Perez EM, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr. 2005;135:267-272.
77. Murray-Kolb LE, Beard JL. Iron deficiency and child and maternal health. Am J Clin Nutr. 2009;89:946S-950S.
78. Bodnar LM, Siega-Riz AM, Miller WC, Cogswell ME, McDonald T. Who should be screened for postpartum anemia? An evaluation of current recommendations. Am J Epidemiol. 2002;156:903-912.
79. Milman N. Postpartum anemia II: prevention and treatment. Ann Hematol. 2012;91:143-154.
80. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S, et al. 'Fit to fly': overcoming barriers to preoperative haemoglobin optimization in surgical patients. Br J Anaesth. 2015;115:15-24.
81. Haas T, Fries D, Tanaka KA, Asmis L, Curry NS, Schöchl H. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth. 2015;114:217-224.
82. Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood. 2014;124:1727-1736.
83. de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011;20:135-141.
84. Green L, Knight M, Seeney F, et al. The haematological features and transfusion management of women who required massive transfusion for major obstetric haemorrhage in the UK: a population based study. Br J Haematol. 2016;172:616-624.
85. Charbit B, Mandelbrot L, Samain E, et al; PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266-273.
86. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108:984-989.
87. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med. 2011;37:1816-1825.
88. de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv. 2012;67:426-435.
89. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia. 2015;70:166-175.
90. Alam A, Choi S. Prophylactic use of tranexamic acid for postpartum bleeding outcomes: a systematic review and metaanalysis of randomized controlled trials. Transfus Med Rev. 2015;29:231-241.
91. Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Antifibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth. 2009;9:29.
92. Sentilhes L, Lasocki S, Ducloy-Bouthors AS, et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth. 2015;114:576-587.
93. Shakur H, Elbourne D, Gülmezoglu M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010;11:40.
94. Alfirevic Z, Elbourne D, Pavord S, et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Obstet Gynecol. 2007;110:1270-1278.
95. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG. 2007;114:8-15.
96. Phillips LE, McLintock C, Pollock W, et al; Australian and New Zealand Haemostasis Registry. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg. 2009;109:1908-1915.
97. Sobieszczyk S, Breborowicz GH, Platicanov V, Tanchev S, Kessler CM. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstet Gynecol Scand. 2006;85:1239-1247.
98. Wikkelsø AJ, Edwards HM, Afshari A, et al; FIB-PPH trial group. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth. 2015;114:623-633.
99. Aawar N, Alikhan R, Bruynseels D, et al. Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial. Trials. 2015;16:169.
100. Ducloy-Bouthors AS, Mignon A, Huissoud C, Grouin JM, Mercier FJ. Fibrinogen concentrate as a treatment for post-partum haemorrhage-induced coagulopathy: a study protocol for a randomized multicentre controlled trial. The FIbrinogen in haemorrhage of DELivery (FIDEL) trial. Anaesth Crit Care Pain Med. 2016 [epub ahead of print].
101. Collins P, Abdul-Kadir R, Thachil J; Subcommittees on Women' s Health Issues in Thrombosis and Haemostasis and on Disseminated Intravascular Coagulation. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14:205-210.
102. Institute for Healthcare Improvement. Evidence-based care bundles. Available at: http://www.ihi.org/resources/Pages/ ImprovementStories/WhatIsaBundle.aspx Accessed March 30, 2016.
103. Wanderer JP, Ehrenfeld JM. Clinical decision support for perioperative information management systems. Semin Cardiothorac Vasc Anesth. 2013;17:288-293.
104. Brouwers MC, Kho ME, Browman GP, et al; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182:E839-E842.